Gold vs US Dollar

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics Inc (KYMR) Financials

KYMR Kymera Therapeutics Inc

45.98

0.00 (0.00%)

Pre Market

Last Updated: 09:10:24

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-97.068	-51.259	-18.097	-18.337	-25.608	-24.932
Return on Equity (%)	124.678	75.791	-52.17	-26.957	-32.598	-33.207
Return on Invested Capital (%)	-109.48	-115.232	-59.977	-44.9	-49.061	-50.403
Operating Margin (%)	N/A	-1404.226	-133.625	-137.36	-330.227	-186.744
Net Profit Margin (%)	N/A	-1405.794	-160.554	-137.6	-330.603	-186.994
Book Value Per Share	16.529	11.269	6.335	8.919	8.906	7.118
Earnings Per Share	-9.1	-13.405	-1.219	-1.945	-2.813	-2.649
Cash Per Share	17.49	24.704	0.692	0.931	1.243	1.982
Working Capital Per Share	15.728	18.939	4.278	6.961	6.324	5.76
Operating Profit Per Share	N/A	0.954	0.76	1.413	0.851	1.416
EBIT Per Share	-9.1	-13.405	-1.017	-1.945	-2.813	-2.649
EBITDA Per Share	-9.1	-13.405	-1.017	-1.945	-2.813	-2.649
Free Cash Flow Per Share	-8.612	-13.5	-1.056	-1.96	-2.815	-2.091

Liquidity Ratios

Year End 31 December 2023	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	2.36M	3.08M	44.81M	51.54M	55.04M	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	55.04M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-431.787	N/A	N/A	N/A	-471.352	N/A	N/A
Net Profit Margin (%)	N/A	-432.368	N/A	N/A	N/A	-472.023	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	2.98B
Price to Earnings Ratio	-20.26
Price to Sales Ratio	37.89
Price to Cash Ratio	27.08
Price to Book Ratio	7.54
Dividend Yield	-

Share Statistics

Shares Outstanding	64.77M
Average Volume (1 week)	590.07k
Average Volume (1 Month)	470.82k
52 Week Change	133.40%
52 Week High	53.27
52 Week Low	18.89

More Ratios Coming Soon!

Kymera Therapeutics

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions